Form 4: Exelixis CFO Christopher J. Senner Acquires Shares Through Performance-Based Vesting

Exelixis's CFO, Christopher J. Senner, acquired 132,973 shares of common stock due to the vesting of performance-based restricted stock units, while also disposing of shares to cover tax obligations.

Summary

• Christopher J. Senner, the EVP and CFO of Exelixis, Inc., acquired 132,973 shares of common stock on January 16, 2025, as a result of the vesting of performance-based restricted stock units (PSUs).
• These PSUs were initially granted on March 4, 2022, and vest based on the achievement of certain performance criteria.
• The Compensation Committee certified the achievement of these criteria on January 16, 2025, leading to the vesting of 50% of the achieved shares immediately, with the remaining 50% scheduled to vest on February 15, 2026.
• Additionally, 35,949 shares were disposed of on the same day to cover tax obligations related to the vesting of the PSUs at a price of $37.27 per share.
• Senner also holds 2,723 shares indirectly through the Exelixis, Inc. 401(k) Plan.

Sentiment

Score: 7

Explanation: The document reflects a positive event (vesting of shares due to performance) but also includes a negative (disposal of shares for tax). Overall, it's a neutral to slightly positive event.

Positives

• The vesting of performance-based restricted stock units indicates that the company has met certain performance criteria.
• The acquisition of a significant number of shares by the CFO suggests confidence in the company's future performance.

Negatives

• The disposal of 35,949 shares to cover tax obligations resulted in a reduction of the total shares held by the CFO.

Risks

• Future vesting of the remaining 50% of the achieved shares is contingent on the CFO's continuous service through February 15, 2026.

Future Outlook

The remaining 50% of the achieved shares will vest on February 15, 2026, contingent on the CFO's continuous service.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It reflects the company's compensation structure and the alignment of management's interests with shareholders through equity-based incentives.

Comparison to Industry Standards

• The use of performance-based restricted stock units is a common practice among publicly traded companies to incentivize executives.
• The vesting schedule, with a portion vesting immediately upon performance certification and the remainder vesting later, is also a typical approach.
• The disposal of shares to cover tax obligations is a standard procedure in such transactions.
• Companies like Gilead Sciences, Amgen, and Biogen also use similar equity-based compensation plans for their executives.

Stakeholder Impact

• Shareholders may view the vesting of shares as a positive sign of the company's performance.
• The disposal of shares for tax obligations has a minor negative impact on the total shares held by the CFO.

Next Steps

• The remaining 50% of the achieved shares will vest on February 15, 2026, subject to the CFO's continuous service.

Key Dates

Keywords

Exelixis, Christopher J. Senner, CFO, Performance-Based Restricted Stock Units, PSU, Stock Vesting, Equity Incentive Plan, SEC Form 4, Insider Trading